The PD-1/PD-L1 pathway is a major contributor to cancer progression by suppressing anti-cancer immune responses (Billon et al., 2019), which implies that PD1/PDL1 is an important factor that causes evasion of immunity (Dong et al., 2002; Iwai et al., 2002). This evidence concerns the gene PDCD1 and cancer.